Hepion Pharmaceuticals
HEPA
$1.37
Share price
6.20%
Change (1 day)
95.71%
Change (1 year)
Categories
Hepion Pharmaceuticals (HEPA) - P/B ratio
P/B ratio as of April 2024 : 0.4640
According to Hepion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.4640.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Hepion Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.93 | 320.4% |
| 2022-12-31 | 0.4592 | -50.86% |
| 2021-12-31 | 0.9344 | -46.01% |
| 2020-12-31 | 1.73 | 34.11% |
| 2019-12-31 | 1.29 | -45.58% |
| 2018-12-31 | 2.37 | -57.99% |
| 2017-12-31 | 5.64 | -53.88% |
| 2016-12-31 | 12.2 | 45.12% |
| 2015-12-31 | 8.43 | 46.74% |
| 2014-12-31 | 5.75 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | 422.96% | 🇺🇸 USA |